Posted in | Nanomedicine | Nanobusiness

BioAlliance Pharma Receives Prestigious Award from the French State

BioAlliance Pharma SA, the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and AIDS, today announced that Madame Dominique Costantini, President of the company's Executive Board, had been awarded the Knight of the Legion of Honor insignia by Professor Claude Griscelli, a former Director of France's INSERM national institute of health and a member of the country's State Council.

The award has been made in recognition of an exceptional physician, researcher and company executive with co-founder of BioAlliance Pharma, Gilles Avenard MD. Professor Claude Griscelli recounted some of the highlights of Dominique Costantini's professional career: "I first met Dominique when she was a student in my department at Necker Children's Hospital. She then moved into the pharmaceutical industry, where I witnessed the development of her tenacity, her sense of

responsibility and, above all, her commitment to getting results - qualities which have enabled her to build BioAlliance Pharma and get its first drug onto the market in under 7 years".

"I am very honored because this insignia is also an award for a growing SME, which I would like to share with Gilles Avenard, my business partner and co-founder of BioAlliance Pharma, and all the company's staff and academic partners, without whom this wonderful corporate adventure would not have been possible," emphasized Dominique Costantini.

Within less than 10 years, BioAlliance Pharma has created an original business model, an integrated pharmaceutical laboratory specialized to the hospital, focusing on patients’ needs and quality of life in oncology and infectious diseases.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit